pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
TNX-4800
Lyme Disease
$TNXP
Tonix Pharmaceuticals Holding Corp.
0
catalysts
Phase 1
TORL-2307 MAB
Gastric Cancer
TORL Biotherapeutics LLC
0
catalysts
Phase 1
TP-317
Crohn's Disease (Regional Enteritis)
Thetis Pharmaceuticals LLC
0
catalysts
Phase 1
← prev
page 21 of 26
next →
131
Pain
89
Neurology
1
TPIV-110
Ductal Carcinoma In Situ
$MRKR
Marker Therapeutics, Inc.
0
catalysts
Phase 1
TPST-1495
Adenocarcinoma Of The Gastroesophageal Junction
$TPST
Tempest Therapeutics, Inc.
0
catalysts
Phase 1
TRE-515
Ovarian Cancer
Trethera Corp
0
catalysts
Phase 1
TRL-345
Cytomegalovirus (HHV-5) Infections
Trellis Bioscience Inc
0
catalysts
Phase 1
TRV-045
Diabetic Neuropathic Pain
Trevena Inc
0
catalysts
Phase 1
TRX-920
Unspecified Cancer
TaiRx Inc
0
catalysts
Phase 1
TSC-203 HLA-A*02:01
Head And Neck Cancer
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 1
TSN-084
Triple-Negative Breast Cancer (TNBC)
Tyligand Biotechnology (Shanghai) Co Ltd
0
catalysts
Phase 1
TST-004
IgA Nephropathy (Berger's Disease)
Transcenta Holding Ltd
0
catalysts
Phase 1
TT-00920
Congestive Heart Failure (Heart Failure)
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-01488
Diffuse Large B-Cell Lymphoma
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-125
Non-Small Cell Lung Cancer
TOLREMO Therapeutics AG
0
catalysts
Phase 1
TTC-352
Metastatic Breast Cancer
TTC Oncology LLC
0
catalysts
Phase 1
TTI-109
Fibrosis
$TVRD
Tvardi Therapeutics, Inc.
0
catalysts
Phase 1
TTX-080
Acral Lentiginous Melanoma
Tizona Therapeutics Inc
0
catalysts
Phase 1
TVGN-489
Coronavirus Disease 2019 (COVID-19)
$TVGN
Tevogen Bio Holdings Inc.
0
catalysts
Phase 1
TXA-709
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
TAXIS Pharmaceuticals Inc
0
catalysts
Phase 1
TYRA-200
Bile Duct Cancer (Cholangiocarcinoma)
$TYRA
Tyra Biosciences, Inc.
0
catalysts
Phase 1
TYRA-430
Metastatic Hepatocellular Carcinoma (HCC)
$TYRA
Tyra Biosciences, Inc.
0
catalysts
Phase 1
UB-621
Genital Herpes
United BioPharma Inc
0
catalysts
Phase 1
UBVV-111
Chronic Lymphocytic Leukemia (CLL)
Umoja BioPharma Inc
0
catalysts
Phase 1
UBX-303
Diffuse Large B-Cell Lymphoma
Ubix Therapeutics Inc
0
catalysts
Phase 1
VAC-85135
Essential Thrombocythemia
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 1
VAR-200
Focal Segmental Glomerulosclerosis (FSGS)
$ZVSA
ZyVersa Therapeutics, Inc.
0
catalysts
Phase 1
VAX-014
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Vaxiion Therapeutics Inc
0
catalysts
Phase 1
VCC-001
Renal Cell Carcinoma
Vaccentis AG
0
catalysts
Phase 1
VG-201
Colorectal Cancer
Virogin Biotech Ltd
0
catalysts
